PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 62 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $8,000 | -97.2% | 9,864 | -95.7% | 0.00% | – |
Q1 2019 | $284,000 | -72.7% | 227,041 | -29.3% | 0.00% | -100.0% |
Q4 2018 | $1,040,000 | +296.9% | 321,121 | +194.2% | 0.00% | – |
Q3 2018 | $262,000 | -4.7% | 109,158 | +10.1% | 0.00% | – |
Q2 2018 | $275,000 | – | 99,174 | +495770.0% | 0.00% | – |
Q1 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
Q4 2017 | $0 | -100.0% | 20 | -100.0% | 0.00% | – |
Q3 2017 | $265,000 | – | 126,307 | +631435.0% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 20 | -99.4% | 0.00% | – |
Q1 2017 | $25,000 | -57.6% | 3,280 | -33.7% | 0.00% | – |
Q4 2016 | $59,000 | -25.3% | 4,945 | -3.8% | 0.00% | – |
Q3 2016 | $79,000 | -58.4% | 5,142 | -67.5% | 0.00% | – |
Q2 2016 | $190,000 | +555.2% | 15,820 | +423.5% | 0.00% | – |
Q1 2016 | $29,000 | – | 3,022 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBOURVEST PARTNERS LLC | 440,627 | $2,093,000 | 2.25% |
NEA Management Company, LLC | 5,556,778 | $26,395,000 | 1.17% |
Endurant Capital Management LP | 472,012 | $2,242,000 | 0.84% |
DAFNA Capital Management LLC | 267,100 | $1,269,000 | 0.62% |
RTW INVESTMENTS, LP | 1,104,940 | $5,248,000 | 0.50% |
DOHENY ASSET MANAGEMENT /CA | 69,625 | $331,000 | 0.17% |
BAILARD, INC. | 520,100 | $2,470,000 | 0.16% |
Bain Capital Public Equity Management, LLC | 399,947 | $1,900,000 | 0.14% |
Rock Springs Capital Management LP | 675,000 | $3,206,000 | 0.14% |
Hillhouse Capital Management | 865,923 | $4,113,000 | 0.07% |